Alectinib as a treatment option following recovery from crizotinib-induced interstitial lung disease in patients with anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer
2016 ◽
Vol 4
(6)
◽
pp. 1085-1087
◽
SHIGENARI NUKAGA
◽
KATSUHIKO NAOKI
◽
TETSURO KAMO
◽
KEITA MASUZAWA
◽
HIROYUKI YASUDA
◽
...
2014 ◽
Vol 2014
(1)
◽
pp. 11-12
◽
V. V. Maka
◽
U. M. Krishnaswamy
◽
N. Anil Kumar
◽
R. Chitrapur
◽
N. Kilara
2015 ◽
Vol 33
(5)
◽
pp. 1148-1150
◽
Yuzo Yamamoto
◽
Isamu Okamoto
◽
Kohei Otsubo
◽
Eiji Iwama
◽
Naoki Hamada
◽
...
Ryota Kikuchi
◽
Hiroyuki Takoi
◽
Takao Tsuji
◽
Yoko Nagatomo
◽
Akane Tanaka
◽
...
Keigo Sekihara
◽
Keiju Aokage
◽
Takashi Hiyama
◽
Hiroaki Oiwa
◽
Tomohiro Miyoshi
◽
...
J.Y. Hwang
◽
C.-H. Park
◽
D.H. Lee
◽
C.H. Kang
◽
C.O. Lee
◽
...
Ryota Kikuchi
◽
Hiroyuki Takoi
◽
Takao Tsuji
◽
Yoko Nagatomo
◽
Akane Tanaka
◽
...
P.-C. Yang
◽
R. Salgia
◽
B. Solomon
◽
A.T. Shaw
◽
D.R. Camidge
◽
...
2019 ◽
Vol Volume 11
◽
pp. 9195-9202
◽
Maobai Liu
◽
Longfeng Zhang
◽
Qishu Huang
◽
Na Li
◽
Bin Zheng
◽
...
2011 ◽
Vol 102
(8)
◽
pp. 1602-1604
◽
Takashi Kijima
◽
Kengo Takeuchi
◽
Satoshi Tetsumoto
◽
Kazuki Shimada
◽
Ryo Takahashi
◽
...
2011 ◽
Vol 364
(6)
◽
pp. 588-588
Close
Export Citation Format
Close
Share Document
Close